cgp 12177 has been researched along with oxytocin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Advenier, C; Bardou, M; Breuiller-Fouché, M; Cecchi, R; Croci, T; Descamps, L; Fradin, Y; Germain, G; Guagnini, F; Leroy, MJ; Marini, P; Pascal, M; Rouget, C; Viviani, N | 1 |
1 other study(ies) available for cgp 12177 and oxytocin
Article | Year |
---|---|
In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agoni
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Benzoates; Binding, Competitive; Cell Line; Cell Line, Tumor; Cells, Cultured; Cyclic AMP; Female; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoproterenol; Macaca fascicularis; Molecular Structure; Myometrium; Obstetric Labor, Premature; Oxytocin; Pregnancy; Propanolamines; Receptors, Adrenergic, beta-3; Sulfonamides; Tocolytic Agents; Transfection; Uterine Contraction; Vasotocin | 2007 |